Hercules Capital logo

Hercules CapitalNYSE: HTGC

Profile

Country:

United States

IPO:

09 June 2005

Next earnings report:

02 August 2024

Last dividends:

13 May 2024

Next dividends:

N/A
$3.33 B
0%vs. 3y high
78%vs. sector
-93%vs. 3y high
29%vs. sector
0%vs. 3y high
71%vs. sector
-62%vs. 3y high
93%vs. sector

Price

regular market | 19 min ago
$20.52+$0.01(+0.05%)
$115.73 M$126.43 M
$115.73 M$90.96 M

Analysts recommendations

Institutional Ownership

HTGC Latest News

Hercules Capital (HTGC) Rises Higher Than Market: Key Facts
zacks.com27 June 2024 Sentiment: -

Hercules Capital (HTGC) concluded the recent trading session at $20.28, signifying a +0.65% move from its prior day's close.

Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
zacks.com21 June 2024 Sentiment: -

In the latest trading session, Hercules Capital (HTGC) closed at $19.82, marking a +0.1% move from the previous day.

Hercules Capital (HTGC) Declines More Than Market: Some Information for Investors
zacks.com14 June 2024 Sentiment: -

In the latest trading session, Hercules Capital (HTGC) closed at $19.57, marking a -0.15% move from the previous day.

Is Hercules Capital the Best Dividend Stock for You?
fool.com14 June 2024 Sentiment: -

This business development company (or BDC) is one of the industry's highest-regarded names. Hercules can afford to pay above-average dividends largely because it is highly focused on the market's most rewarding industries.

Hercules Capital (HTGC) Stock Falls Amid Market Uptick: What Investors Need to Know
zacks.com13 June 2024 Sentiment: -

In the latest trading session, Hercules Capital (HTGC) closed at $19.60, marking a -1.31% move from the previous day.

3 Dividend Stocks to Buy With $5,000 and Hold Forever
fool.com13 June 2024 Sentiment: -

Real estate investment trust Realty Income does business with the world's most resilient retailers. JPMorgan Chase may have seen better days, but its current challenges are neither new nor insurmountable.

Why the Market Dipped But Hercules Capital (HTGC) Gained Today
zacks.com07 June 2024 Sentiment: POSITIVE

In the closing of the recent trading day, Hercules Capital (HTGC) stood at $19.79, denoting a +0.1% change from the preceding trading day.

2 High-Yield Dividend Stocks Billionaires Are Buying Hand Over Fist
The Motley Fool05 May 2024 Sentiment: POSITIVE

Institutional investors are required to report their holdings to the SEC on a quarterly basis. A few wealthy investors made significant investments in AT&T and Hercules Capital in the final quarter of 2023.

Hercules Capital (HTGC) Q1 Earnings Beat Despite Higher Costs
Zacks Investment Research03 May 2024 Sentiment: POSITIVE

Hercules Capital (HTGC) sees year-over-year growth in both total investment income and expenses during the first quarter of 2024.

Compared to Estimates, Hercules Capital (HTGC) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research02 May 2024 Sentiment: POSITIVE

The financial results for Hercules Capital (HTGC) in the first quarter of 2024 provide valuable information on its performance, but it could be beneficial to analyze certain key metrics in comparison to analyst expectations and previous year's figures.

What type of business is Hercules Capital?

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million to $250 million in equity per transactions. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; San Diego, California; Westport, Connecticut; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia and London, United Kingdom.

What sector is Hercules Capital in?

Hercules Capital is in the Financial Services sector

What industry is Hercules Capital in?

Hercules Capital is in the Asset Management industry

What country is Hercules Capital from?

Hercules Capital is headquartered in United States

When did Hercules Capital go public?

Hercules Capital initial public offering (IPO) was on 09 June 2005

What is Hercules Capital website?

https://www.htgc.com

Is Hercules Capital in the S&P 500?

No, Hercules Capital is not included in the S&P 500 index

Is Hercules Capital in the NASDAQ 100?

No, Hercules Capital is not included in the NASDAQ 100 index

Is Hercules Capital in the Dow Jones?

No, Hercules Capital is not included in the Dow Jones index

When does Hercules Capital report earnings?

The next expected earnings date for Hercules Capital is 02 August 2024